Guyasuta Investment Advisors Inc. Sells 1,475 Shares of CVS Health Co. (NYSE:CVS)

Guyasuta Investment Advisors Inc. reduced its stake in shares of CVS Health Co. (NYSE:CVS) by 33.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,891 shares of the pharmacy operator’s stock after selling 1,475 shares during the period. Guyasuta Investment Advisors Inc.’s holdings in CVS Health were worth $228,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of CVS. Exchange Traded Concepts LLC boosted its holdings in CVS Health by 22.8% during the third quarter. Exchange Traded Concepts LLC now owns 5,993 shares of the pharmacy operator’s stock valued at $418,000 after purchasing an additional 1,112 shares in the last quarter. Brookstone Capital Management increased its stake in shares of CVS Health by 18.3% in the 3rd quarter. Brookstone Capital Management now owns 60,115 shares of the pharmacy operator’s stock valued at $4,245,000 after buying an additional 9,303 shares during the period. Sweet Financial Partners LLC raised its holdings in CVS Health by 60.2% during the 3rd quarter. Sweet Financial Partners LLC now owns 20,971 shares of the pharmacy operator’s stock worth $1,464,000 after purchasing an additional 7,877 shares during the last quarter. Accurate Wealth Management LLC raised its stake in shares of CVS Health by 4.9% during the third quarter. Accurate Wealth Management LLC now owns 3,144 shares of the pharmacy operator’s stock worth $226,000 after buying an additional 148 shares during the last quarter. Finally, Ulland Investment Advisors LLC raised its stake in shares of CVS Health by 25.3% during the third quarter. Ulland Investment Advisors LLC now owns 1,856 shares of the pharmacy operator’s stock worth $130,000 after buying an additional 375 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Insider Activity at CVS Health

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the sale, the executive vice president now owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.24% of the stock is owned by corporate insiders.

CVS Health Stock Up 0.4 %

Shares of CVS Health stock opened at $67.44 on Tuesday. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. CVS Health Co. has a 1 year low of $64.41 and a 1 year high of $83.25. The firm’s 50-day moving average is $74.22 and its two-hundred day moving average is $73.65. The stock has a market cap of $85.01 billion, a price-to-earnings ratio of 10.44, a PEG ratio of 0.89 and a beta of 0.52.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, beating analysts’ consensus estimates of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The business had revenue of $93.81 billion for the quarter, compared to analysts’ expectations of $90.58 billion. During the same period last year, the business earned $1.99 EPS. The company’s revenue was up 11.9% compared to the same quarter last year. As a group, research analysts expect that CVS Health Co. will post 8.31 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.94%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is 41.18%.

Analysts Set New Price Targets

CVS has been the topic of a number of analyst reports. Barclays initiated coverage on shares of CVS Health in a research note on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price objective on the stock. Wells Fargo & Company reduced their price objective on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating on the stock in a research note on Monday, April 8th. Piper Sandler increased their target price on shares of CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, March 15th. Royal Bank of Canada dropped their target price on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a report on Thursday, February 8th. Finally, Leerink Partnrs reissued an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $89.44.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.